Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Non Operating Income (2016 - 2023)

Pharma-Bio Serv filings provide 13 years of Non Operating Income readings, the most recent being $126985.0 for Q3 2023.

  • On a quarterly basis, Non Operating Income rose 336.55% to $126985.0 in Q3 2023 year-over-year; TTM through Jul 2023 was $628228.0, a 1426.66% increase, with the full-year FY2022 number at $13418.0, down 99.32% from a year prior.
  • Non Operating Income hit $126985.0 in Q3 2023 for Pharma-Bio Serv, down from $192616.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.0 million in Q3 2021 to a low of -$53683.0 in Q3 2022.
  • Median Non Operating Income over the past 5 years was $48584.0 (2020), compared with a mean of $167833.2.
  • Biggest five-year swings in Non Operating Income: crashed 136.9% in 2020 and later surged 39988.62% in 2023.
  • Pharma-Bio Serv's Non Operating Income stood at $57436.0 in 2019, then fell by 28.31% to $41178.0 in 2020, then plummeted by 96.82% to $1310.0 in 2021, then soared by 4639.08% to $62082.0 in 2022, then soared by 104.54% to $126985.0 in 2023.
  • The last three reported values for Non Operating Income were $126985.0 (Q3 2023), $192616.0 (Q2 2023), and $246545.0 (Q1 2023) per Business Quant data.